who is not a good candidate for glp 1 Should Consider Semaglutide GLP-1? Semaglutide GLP-1 generally recommended individuals with type 2 diabetes who have achieved adequate blood sugar control with other medications such as metformin, or for Are GLP1’s For Everyone? Which

The Female Sexual Response: Anatomy and Physiology of Sexual Desire, Arousal, and Orgasm in Women

Mller, Finan B ,Bloom S R , et al

Perfect complement to semaglutide or tirzepatide programs

India Patent expires: March 2026 Adult population: 947 million Proportion of adults living with obesity a : 8% Proportion of adults living with diabetes b : 11% China Patent expires: March 2026 Adult population: 1.07 billion Proportion of adults living with obesity a : 9% Proportion of adults living with diabetes b : 12% Brazil Patent expires: March 2026 Adult population: 155 million Proportion of adults living with obesity a : 31% Proportion of adults living with diabetes b : 11% Trkiye Patent expires: 2026 Adult population: 59.0 million Proportion of adults living with obesity a : 36% Proportion of adults living with diabetes b : 16% Canada Patent expires: 2026 Adult population: 29.1 million Proportion of adults living with obesity a : 27% Proportion of adults living with diabetes b : 10% World Population: 8.23 billion More than 1 billion people in the world have a body mass index (BMI) 30 kg/m 2

It greatly increases the likelihood of developing prediabetes and, eventually, type 2 diabetes

The team defined discontinuation as having more than a 60-day gap in GLP-1 prescription refills